While Novo Nordisk says CagriSema will help users lose up to 25% of weight, duration will be clear when final results of its ...

Excitement is building around a new weight loss drug, CagriSema, which is expected to surpass the effects of popular drugs ...

The SA Health Products Regulatory Authority has expressed concern at the increasing presence of counterfeit products such as ...

These pose a health risk to the public. Sahpra cautions the public to not purchase and/or consume such products as their ...

So what is semaglutide and who uses it in India? Semaglutide belongs to the class of drugs called Glucagon-like peptide-1 ...

Novo Nordisk's stock has dropped to $110 per share, but operational performance remains strong. See why I believe we are at ...

Don't buy the Ozempic or Mounjaro you see online, warns SAHPRA, because you may be wasting your money or risking your health.

Losing weight on GLP-1 drugs like Ozempic isn't guaranteed. Experts reveal how to tell if yours isn't working and the next steps you should take to reach your weight loss goals.

Vivani Medical Provides Business Update Including $5M Equity Financing and Reports Third Quarter 2024 Financial Results ...

SAHPRA cautions the public to not purchase and/or consume such products as their safety, efficacy, and quality have not been ...